Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

Investor

Investingwilly

Community Contributor

The "Boring" Money Printer

Meet Investor AB In a financial world often rocked by inflation, geopolitical shocks, and rapidly changing technology, few companies offer the kind of steady hand that Investor AB does. As Sweden’s largest investment company and a key part of the Wallenberg sphere , Investor AB has shown an unmatched ability to weather economic turbulence – not just for a few years, but for over a century.

View narrative

SEK 350.00

18.1% undervalued

10.79%

Revenue growth p.a.

16 days ago

Bayerische Motoren Werke

Unike

Community Contributor

BMW cruising ahead with new EVs and premium models to boost revenue 5%

Catalysts Most Immediate Catalysts (1–2 Years) Strong EV Expansion: BMW’s iX, i4, and upcoming Neue Klasse EVs are set to drive revenue growth as the EV transition accelerates. Luxury & Premium Market Strength: The high-end market remains resilient, supporting BMW’s strong pricing power and margins.

View narrative

€135.07

45.0% undervalued

5.00%

Revenue growth p.a.

about 1 month ago

Novo Nordisk

Tokyo

Community Contributor

EU#2 - From Humble Beginnings to Global Powerhouse

Novo Nordisk, one of the world’s leading pharmaceutical companies, has a unique and inspiring origin story rooted in personal tragedy and scientific curiosity. The company’s roots date back to the 1920s, when Danish Nobel laureate August Krogh, a renowned physiologist, and his wife Marie, who suffered from type 2 diabetes, traveled to Canada.

View narrative

DKK 851.04

48.9% undervalued

14.00%

Revenue growth p.a.

13 days ago

Load previous narratives

UnitedHealth Group

WallStreetWontons

Community Contributor

UNH: Valuations Seem Lofty for this Managed Healthcare Giant

Catalysts Products and Services: In 2021, products contributed $34.4 billion in revenues, while services brought in $24.6 billion. Approximately 79% of UnitedHealth Group’s revenue is generated from premiums.

View narrative

US$486.86

15.5% undervalued

9.81%

Revenue growth p.a.

9 months ago

Dedicare

Bonywall

Community Contributor

Staff Shortages and Demographic Shifts Could Drive Revenue Higher Despite Competition and Regulatory Challenges

Key Takeaways Dedicare holds a robust market position within a steadily expanding market. Continued revenue growth is supported by the persistent need for skilled health professionals.

View narrative

SEK 82.20

49.4% undervalued

9.72%

Revenue growth p.a.

9 months ago

Perfect Medical Health Management

Lahmstanley

Community Contributor

Good Prospects if management is strategic. Fair value between 4 - 9 HKD.

Summary Estimated Liquidating Value - March 2024 - 0.16 HKD Business Value Range 4 - 9 HKD. Dividend Record - 11 years uninterrupted.

View narrative

HK$9.00

75.9% undervalued

37.76%

Revenue growth p.a.

9 months ago

AT&T

Goran_Damchevski

Equity Analyst

Stabilization And Incremental Progress Will Unlock Value

Key Takeaways AT&T is emerging from an unstable phase with questionable performance and a large debt burden. Sentiment will pick up as the company demonstrates fundamental improvements and recapitalizes its structure.

View narrative

US$32.12

13.8% undervalued

2.00%

Revenue growth p.a.

10 months ago

Tesla

FineAnts

Community Contributor

Navigating the Future: Analysis of Tesla's Growth and Challenges

Catalysts FSD (Supervised): This is Tesla's Full Self-Driving technology. As it progresses towards full autonomy, consider the potential for mass adoption and its impact on Tesla's brand and sales.

View narrative

US$332.98

15.3% undervalued

40.05%

Revenue growth p.a.

10 months ago

Generac Holdings

julio

Community Contributor

Generac valuation

Bull Generac is the undisputed leader in home standby generators, with over 70% market share. Generac is expanding into clean energy via acquisitions, representing a large and growing addressable market.

View narrative

US$144.95

21.1% undervalued

9.35%

Revenue growth p.a.

10 months ago

Caterpillar

julio

Community Contributor

cat valuation

Bullsu Increased infrastructure spending in the US and emerging markets will lead to more construction equipment purchases, substantially boosting Caterpillar's sales growth. Higher fixed-asset investment growth in China strengthens support for increased investment in mining capital expenditures, benefiting Caterpillar.

View narrative

US$332.91

7.1% undervalued

3.14%

Revenue growth p.a.

10 months ago

Southwest Airlines

julio

Community Contributor

LUV valuation

Catalysts Are there any products or services that could move sales or earnings meaningfully? Are there any industry tailwinds this stock is benefitting or hindered from?

View narrative

US$34.80

19.7% undervalued

15.39%

Revenue growth p.a.

10 months ago

TIER 1 Technology

A_Stricek

Community Contributor

Tier 1 doing a great job, but external factors slow it down.

· The company's stock value has declined this week due to economic and political circumstances in Spain and Europe, particularly with the potential exit of France from the Euro. However, the company's strong fundamentals suggest it will continue on an upward trend, albeit at a slower pace.

View narrative

€2.28

31.6% overvalued

4.00%

Revenue growth p.a.

10 months ago

Community